Search results
AbbVie (NYSE:ABBV) Stock Price Up 1.5% on Analyst Upgrade
ETF DAILY NEWS· 24 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.5% during trading on Tuesday after Piper Sandler raised their price target on the stock from $185.00 to $190.00. Piper ...
Canandaigua National Bank & Trust Co. Trims Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 14 hours agoCanandaigua National Bank & Trust Co. reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% in the 1st quarter, according to the company in its most ...
AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis
Pharmaceutical Technology via Yahoo Finance· 17 hours agoAbbVie has announced receipt of US Food and Drug Administration (FDA) approval for SKYRIZI...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Tri-County Times· 1 day agoAbbVie logo (PRNewsFoto/AbbVie)
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
Motley Fool via Yahoo Finance· 17 hours agoUnlike growth stocks, you don't have to sell shares to receive cash. Companies that pay dividends...
Here's Why AbbVie (ABBV) is a Strong Momentum Stock
Zacks via Yahoo Finance· 11 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.
ETF DAILY NEWS· 5 days agoGarde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Vanguard Group Inc.
ETF DAILY NEWS· 2 days agoVanguard Group Inc. trimmed its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and ...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 2 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 20 hours agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the United States. Skyrizi ...